Import Ashwagandha — Buy in Bulk from Supplier in India

Ashwagandha from Buoimmune Synergies India Private Limited is a hydroalcoholic extract derived from the root of Withania somnifera, a native Indian Ayurvedic herb. The supplier specialises in extracts for traditional medicine, leveraging India’s exclusive cultivation of this adaptogenic crop. Withania somnifera has been integral to Ayurvedic practice for over 3000 years, valued for its stress-modulating and rejuvenating properties in classical formulations.

The extract is processed to retain bioactive withanolides, alkaloids and steroidal lactones typical of standard Ashwagandha root preparations. Industry standards for such extracts often include a minimum 1.5% withanolides content, measured via HPLC, though the supplier’s exact concentration should be confirmed. Ashwagandha root extracts are commonly available in powder form, with typical particle sizes ranging from 80 to 120 mesh for ease of formulation in capsules, tablets or liquid preparations.

Buyers of this extract include manufacturers of herbal supplements, Ayurvedic medicine producers and nutraceutical brands targeting stress relief, energy support and immune modulation. The product is suited for bulk import, with packaging and lead times to be confirmed directly with the supplier. Origin verification is straightforward, as commercial Ashwagandha cultivation is concentrated in India, particularly in regions like Telangana where Buoimmune Synergies is based.

Buoimmune Synergies India Private Limited operates from Shed No. 2A1 in IDA Phase 4, Cherlapally, Hyderabad, Telangana. The company is positioned within India’s pharmaceutical and herbal extract manufacturing hub, an area known for its adherence to Ayurvedic processing traditions. Its address places it in a regulated industrial zone, which often indicates compliance with local manufacturing norms for botanical extracts.

The supplier’s profile indicates a focus on hydroalcoholic extracts of Ayurvedic herbs, with Ashwagandha root extract as a core offering. While the response rate and verification signals are not currently available, the company’s stated specialisation aligns with the demands of traditional medicine manufacturers. No additional details on certifications, production capacity or client base are provided in the listing, so buyers should request these directly.